T1	Participants 79 121	HIV-associated B-cell non-Hodgkin lymphoma
T2	Participants 713 731	HIV-associated NHL
T3	Participants 962 983	48 evaluable patients
T4	Participants 1078 1099	53 evaluable patients
T5	Participants 1479 1502	HIV-associated lymphoma
